Composition
- Active ingredients
- CABAZITAXEL 60MG/1.5ML (40MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA201023.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Jevtana Kit
- Active substance
- cabazitaxel
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Sanofi Aventis US
- Status
- Prescription
- FDA approval
- 17 Jun 2010
- Application
- NDA201023-001



